专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 再颁专利

USRE34653E Heterocyclic spiro compounds and methods for preparing the same 失效
标题翻译：杂环螺环化合物及其制备方法
公开(公告)号：USRE34653E
公开(公告)日：1994-07-05
申请号：US909639
申请日：1992-07-07
申请人： Shin-ichi Tsukamoto , Hitoshi Nagaoka , Shinji Usuda , Masatomi Harada , Toshinari Tamura
发明人： Shin-ichi Tsukamoto , Hitoshi Nagaoka , Shinji Usuda , Masatomi Harada , Toshinari Tamura
IPC分类号： C07D491/107 , A61K31/435 , A61K31/55 , A61P25/02 , A61P25/28 , C07D211/48 , C07D405/06 , C07D453/00 , C07D471/10 , C07D487/10 , C07D491/10 , C07D491/20 , C07D491/22 , C07D495/10 , C07D495/20 , C07D495/22 , C07D497/20 , C07D497/22 , C07D705/02
CPC分类号： C07D471/10 , C07D211/48 , C07D491/10 , C07D495/10
摘要： Heterocyclic spiro compounds represented by the following general formula and salts thereof: ##STR1## The above compounds act upon muscarinic acetylcholine receptors, thereby activating the acetylcholine nervous functions in the central nervous system.
摘要翻译：由以下通式表示的杂环螺环化合物及其盐：上述化合物作用于毒蕈碱性乙酰胆碱受体，由此激活中枢神经系统中的乙酰胆碱神经功能。

2. 发明授权

US4996210A Heterocyclic spiro compounds and methods for preparing the same 失效
标题翻译：杂环螺环化合物及其制备方法
公开(公告)号：US4996210A
公开(公告)日：1991-02-26
申请号：US470091
申请日：1990-01-25
申请人： Shin-ichi Tsukamoto , Hitoshi Nagaoka , Shinji Usuda , Masatomi Harada , Toshinari Tamura
发明人： Shin-ichi Tsukamoto , Hitoshi Nagaoka , Shinji Usuda , Masatomi Harada , Toshinari Tamura
IPC分类号： C07D491/107 , A61K31/435 , A61K31/55 , A61P25/02 , A61P25/28 , C07D211/48 , C07D405/06 , C07D453/00 , C07D471/10 , C07D487/10 , C07D491/10 , C07D491/20 , C07D491/22 , C07D495/10 , C07D495/20 , C07D495/22 , C07D497/20 , C07D497/22
CPC分类号： C07D471/10 , C07D211/48 , C07D491/10 , C07D495/10
摘要： Heterocyclic spiro compounds represented by the following general formula and salts thereof ##STR1## The above compounds act upon muscarinic acetylcholine receptors, thereby activating the acetylcholine nervous functions in the central nervous system.

3. 发明授权

US4940795A Heterocyclic spiro compounds and methods for preparing the same 失效
标题翻译：杂环螺环化合物及其制备方法
公开(公告)号：US4940795A
公开(公告)日：1990-07-10
申请号：US254375
申请日：1988-10-05
申请人： Shin-ichi Tsukamoto , Hitoshi Nagaoka , Shinji Usuda , Masatomi Harada , Toshinari Tamura
发明人： Shin-ichi Tsukamoto , Hitoshi Nagaoka , Shinji Usuda , Masatomi Harada , Toshinari Tamura
IPC分类号： C07D491/107 , A61K31/435 , A61K31/55 , A61P25/02 , A61P25/28 , C07D211/48 , C07D405/06 , C07D453/00 , C07D471/10 , C07D487/10 , C07D491/10 , C07D491/20 , C07D491/22 , C07D495/10 , C07D495/20 , C07D495/22 , C07D497/20 , C07D497/22
CPC分类号： C07D471/10 , C07D211/48 , C07D491/10 , C07D495/10
摘要： Heterocyclic spiro compounds represented by the following general formula and salts thereof: ##STR1## The above compounds act upon muscarinic acetylcholine receptors, thereby activating the acetylcholine nervous functions in the central nervous system.

4. 发明授权

US5412096A Hydrochloride salts of heterocyclic spiro compounds 失效
标题翻译：杂环螺环化合物的盐酸盐
公开(公告)号：US5412096A
公开(公告)日：1995-05-02
申请号：US230625
申请日：1994-05-24
申请人： Shin-ichi Tsukamoto , Hitoshi Nagaoka , Shinji Usuda , Masatomi Harada , Toshinari Tamura
发明人： Shin-ichi Tsukamoto , Hitoshi Nagaoka , Shinji Usuda , Masatomi Harada , Toshinari Tamura
IPC分类号： C07D211/48 , C07D471/10 , C07D491/10 , C07D491/107 , C07D491/20 , C07D491/22 , C07D495/10 , C07D495/20 , C07D495/22 , C07D497/20 , C07D497/22 , C07D405/02
CPC分类号： C07D471/10 , C07D211/48 , C07D491/10 , C07D495/10
摘要： Hydrochloride salts of heterocyclic spiro compounds are provided and can be represented by the following general formula: ##STR1## wherein A represents piperidine or N alkyl piperidine or N alkylene attached to a non adjacent piperidine ring carbon, X is S or O, Y is carbonyl, thiocarbonyl, methylene, R.sup.5 methylene, ##STR2## alk in which R.sup.1 to R.sub.3,R.sub.6,R.sub.7 are H or alkyl, R.sub.4 is H, alkyl, COOH, or ester, or --C alkyl, R.sub.5 is halo, OH,SH, O alkyl, S alkyl, O acyl or S acyl, and Z, and Z.sub.2 are O or S. The above compounds act upon muscarinic acetylcholine receptors, thereby activating the acetylcholine nervous functions in the central nervous system.
摘要翻译：提供了杂环螺环化合物的盐酸盐，并且可以由以下通式表示：其中A表示哌啶或N烷基哌啶或连接于非相邻哌啶环碳的N亚烷基，X为S或O，Y为羰基，其中R 1至R 3，R 6，R 7为H或烷基，R 4为H，烷基，COOH或酯或-C烷基，R 5为卤素，OH，SH， O烷基，S烷基，O酰基或S酰基，Z和Z2是O或S.上述化合物作用于毒蕈碱性乙酰胆碱受体，从而激活中枢神经系统中的乙酰胆碱神经功能。

5. 发明授权

US5041549A Heterocyclic spiro compounds and methods for preparing the same 失效
公开(公告)号：US5041549A
公开(公告)日：1991-08-20
申请号：US470093
申请日：1990-01-25
申请人： Shin-ichi Tsukamoto , Hitoshi Nagaoka , Shinji Usuda , Masatomi Harada , Toshinari Tamura
发明人： Shin-ichi Tsukamoto , Hitoshi Nagaoka , Shinji Usuda , Masatomi Harada , Toshinari Tamura
IPC分类号： C07D491/107 , A61K31/435 , A61K31/55 , A61P25/02 , A61P25/28 , C07D211/48 , C07D405/06 , C07D453/00 , C07D471/10 , C07D487/10 , C07D491/10 , C07D491/20 , C07D491/22 , C07D495/10 , C07D495/20 , C07D495/22 , C07D497/20 , C07D497/22
CPC分类号： C07D471/10 , C07D211/48 , C07D491/10 , C07D495/10
摘要： Heterocyclic spiro compounds represented by the following general formula and salts thereof: ##STR1## wherein A represents piperidine or N alkyl piperidine or N alkylene attached to a non adjacent piperidine ring carbon, X is S or O, Y is carbonyl, thiocarbonyl, methylene, R.sup.5 methylene, ##STR2## in which R.sup.1 to R.sub.3, R.sub.6, R.sub.7 are H or alkyl, R.sub.4 is H, alkyl, --COOH, or ester, or ##STR3## R.sub.5 is halo, OH, SH, O alkyl, S alkyl, O acyl or S acyl, and Z.sub.1 and Z.sub.2 are O or S.The above compounds act upon muscarinic acetylcholine receptors, thereby activating the acetylcholine nervous functions in the central nervous system.

6. 发明授权

US4987132A Saturated heterocyclic carboxamide derivatives 失效
标题翻译：饱和杂环羧酰胺衍生物
公开(公告)号：US4987132A
公开(公告)日：1991-01-22
申请号：US232899
申请日：1988-08-16
申请人： Toshiyasu Mase , Hiromu Hara , Hitoshi Nagaoka , Takumi Takahashi , Takeshi Suzuki , Kenichi Tomioka , Toshimitsu Yamada
发明人： Toshiyasu Mase , Hiromu Hara , Hitoshi Nagaoka , Takumi Takahashi , Takeshi Suzuki , Kenichi Tomioka , Toshimitsu Yamada
IPC分类号： C07D401/04 , C07D405/04 , C07D413/04 , C07D417/04 , C07D417/14
CPC分类号： C07D401/04 , C07D405/04 , C07D413/04 , C07D417/04 , C07D417/14
摘要： A saturated heterocyclic carboxamide derivative of the following general formula (I) and salts thereof which have platelet activating factor (PAF) antagonizing activity. ##STR1##

7. 发明授权

US6090615A Method for extracting a Basidiomycetes mycelium-containing culture medium using .beta.-1,3-glucanase 失效
标题翻译：使用β-1,3-葡聚糖酶提取担子菌菌丝体培养基的方法
公开(公告)号：US6090615A
公开(公告)日：2000-07-18
申请号：US779946
申请日：1996-12-23
申请人： Hitoshi Nagaoka
发明人： Hitoshi Nagaoka
IPC分类号： A61K8/99 , A61Q19/00 , C12N1/06 , C02F1/00 , C07G17/00 , C12P1/00
CPC分类号： C12N1/06
摘要： Useful ingredients are extracted from a mycelium-containing culture medium by the steps of inoculating basidiomycetes in a solid culture medium containing bagasse as a substrate and proliferating mycelium, and then squeezing the solid culture medium containing proliferated mycelium to obtain a squeeze liquid (i), separately, adding water and beta 1,3, glucanase and at least one enzyme selected from the group consisting of chitinase, cellulase and protease to a mycelium-containing solid residue having been separated from the squeeze liquid (i), stirring the resulting mixture with maintaining the mixture at 30 to 60.degree.0 C. to lyse mycelial cell walls, and heating the resulting cell wall lysis product-containing liquid (ii) up to a temperature of 95.degree. C. to inactivate the enzyme and perform sterilization. The cell wall lysis product-containing liquid (ii) contains .beta.-glucan in a high concentration and shows excellent antitumor effects. The obtained squeeze liquid (i) contains cytokinin-like substances in high concentrations together with metabolites of the mycelium, and this liquid is clear; therefore, application of this liquid to tonic drinks, plant hormone drugs and cosmetic materials can be expected.
摘要翻译：通过以下步骤从含菌丝体培养基中提取有用成分：将担子菌在含有甘蔗渣作为底物和增殖菌丝体的固体培养基中接种，然后挤压含有增殖菌丝体的固体培养基，得到挤压液（i）分别将水和β1,3葡聚糖酶和至少一种选自几丁质酶，纤维素酶和蛋白酶的酶分离到从挤压液体中分离的含有菌丝体的固体残渣（i）中，将所得混合物与将混合物保持在30至60℃以裂解菌丝体细胞壁，并将得到的含细胞壁裂解产物的液体（ii）加热至95℃以灭活酶并进行灭菌。含有细胞壁裂解产物的液体（ii）含有高浓度的β-葡聚糖，显示出优异的抗肿瘤作用。所获得的挤压液（i）含有高浓度的细胞分裂素样物质和菌丝体的代谢物，该液体是清澈的; 因此，可以预期将这种液体用于补品饮料，植物激素药物和化妆品材料。

8. 发明授权

US5447803A Method for forming titanium nitride film and vessel coated by same 失效
标题翻译：用于形成氮化钛膜和用其涂覆的容器的方法
公开(公告)号：US5447803A
公开(公告)日：1995-09-05
申请号：US171248
申请日：1993-12-20
申请人： Hitoshi Nagaoka , Hiroshi Kanno
发明人： Hitoshi Nagaoka , Hiroshi Kanno
IPC分类号： A47J36/02 , C23C14/06 , C23C14/58 , C23C16/34 , C23C16/56 , B05D3/02 , C23C16/40
CPC分类号： C23C14/5806 , A47J36/02 , C23C14/0641 , C23C14/58 , C23C14/5853 , C23C16/34 , C23C16/56
摘要： A titanium nitride film forming method employing an ion-plating method to produce good decorative properties, to a titanium nitride film forming method which can maintain the stability of the color tone even under high temperatures, and to the vessel obtained through the above methods. The titanium nitride film-forming method used in the present invention is; (1) a titanium nitride film-forming method wherein a titanium nitride film is formed over the surface of a substrate by either the physical metalizing method or the chemical metalizing method, (2) a titanium nitride film-forming method wherein a titanium nitride film is formed over the surface of a substrate, and the substrate is, then, heated in a mixed atmosphere of oxygen and nitrogen, thereby forming a transparent and stable titanium oxide film over the surface of the titanium nitride film, and (3) the titanium nitride film forming method wherein a titanium nitride film is formed over the surface of a substrate, and the substrate is, then, heated in an nitrogen atmosphere, thereby effecting a color tone stabilizing treatment which diffuses nitrogen into the titanium nitride film. The respective titanium nitride film-forming methods are used to provide a vessel manufactured by forming the titanium nitride film over the surface of the vessel's substrate.
摘要翻译：对于即使在高温下也能保持色调稳定性的氮化钛膜形成方法和通过上述方法得到的容器，也可以使用采用离子镀法制造良好的装饰性的氮化钛膜形成方法。本发明中使用的氮化钛膜形成方法是：（1）氮化钛膜形成方法，其中通过物理金属化方法或化学金属化方法在衬底的表面上形成氮化钛膜，（2）氮化钛膜形成方法，其中氮化钛膜形成在衬底的表面上，然后在氧和氮的混合气氛中加热衬底，从而在氮化钛膜的表面上形成透明稳定的氧化钛膜，（3）钛氮化膜形成方法，其中在衬底的表面上形成氮化钛膜，然后在氮气气氛中加热衬底，从而进行将氮扩散到氮化钛膜中的色调稳定处理。使用相应的氮化钛膜形成方法来提供通过在容器基板的表面上形成氮化钛膜而制造的容器。

9. 发明授权

US5361562A Method and apparatus for opening lid of box 失效
标题翻译：打开盒子盖的方法和装置
公开(公告)号：US5361562A
公开(公告)日：1994-11-08
申请号：US994294
申请日：1992-12-21
申请人： Hitoshi Nagaoka , Hiroyuki Shimizu , Keizo Nakashima
发明人： Hitoshi Nagaoka , Hiroyuki Shimizu , Keizo Nakashima
IPC分类号： B65B43/40 , B65B69/00
CPC分类号： B65B43/40
摘要： The lid of a box is pushed up from the main body of the box by injecting gas by use of one or more injection nozzles into a gap formed between the lid and main body of the box and then, with part of a top plate of the lid in contact with a lid rotating stopper, gas is further injected into the gap, or the lid is pushed up by injecting gas into the gap by use of one or more lower position injection nozzles and then gas is injected into the gap by use of one or more higher position injection nozzles in one or more stages, before the lid is opened from the main body. Thereby, it is possible to prevent the lids from being opened in a three-dimensional inclined state (in a one-side opened state) as well as to prevent the lid and main body of a box from being pushed upwardly simultaneously.
摘要翻译：通过使用一个或多个注射喷嘴将气体注入到箱体的盖体和主体之间的间隙中，将盒子的盖子从箱体的主体向上推压，然后与顶板的一部分盖子与盖旋转塞子接触，气体被进一步注入到间隙中，或者通过使用一个或多个下位置注入喷嘴将气体注入到间隙中而将盖子推上，然后使用一个或多个更高位置的喷嘴在一个或多个阶段中，在盖从主体打开之前。因此，可以防止盖子以三维倾斜状态（单侧打开状态）打开，并且防止箱体的盖体和主体同时向上推。

10. 发明授权

US07494657B2 Inhibitor of hepatitis B and HIV activity 失效
标题翻译：乙型肝炎抑制剂和艾滋病毒活动
公开(公告)号：US07494657B2
公开(公告)日：2009-02-24
申请号：US10644221
申请日：2003-08-19
申请人： Hitoshi Nagaoka
发明人： Hitoshi Nagaoka
IPC分类号： A61K35/84 , A23L2/38
CPC分类号： A61K36/06 , C12P1/02 , C12R1/645
摘要： The inhibitor of Hepatitis B virus and HIV activity according to the present invention comprises a Lentinus edodes mycelium extract obtained by the steps of inoculating Lentinus edodes fungus in a solid culture medium comprising bagasse, then disentangling the solid culture medium containing the proliferated mycelium, adding water and at least one enzyme selected from a group consisting of cellulase, protease and glucosidase to the disentangled solid culture medium with keeping the solid culture medium at 30 to 50° C., grinding and milling the solid culture medium in the presence of the enzyme to obtain a Lentinus edodes mycelium extract, and then heating the extract to a temperature of not higher than 95° C. to inactivate the enzyme and sterilize the extract.
摘要翻译：根据本发明的乙型肝炎病毒和HIV活性的抑制剂包括通过以下步骤获得的香菇菌丝体提取物，所述香菇菌丝体提取物在包含甘蔗渣的固体培养基中接种香菇菌体，然后将含有增殖菌丝体的固体培养基解开，加入水和至少一种选自纤维素酶，蛋白酶和葡糖苷酶的酶至分离的固定培养基中，同时保持固体培养基在30至50℃，在酶存在下研磨和研磨固体培养基至获得香菇菌丝体提取物，然后将提取物加热至不高于95℃的温度以灭活酶并对提取物进行灭菌。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式